Quinelorane
Appearance
Identifiers | |
---|---|
| |
CAS Number |
|
PubChem CID | |
IUPHAR/BPS | |
ChemSpider | |
UNII |
|
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C14H22N4 |
Molar mass | 246.358 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Quinelorane is a drug which acts as a dopamine agonist for the D2[1][2][3] and D3 receptor.
See also
[edit]References
[edit]- ^ Caine SB, Negus SS, Mello NK, Patel S, Bristow L, Kulagowski J, Vallone D, Saiardi A, Borrelli E (April 2002). "Role of dopamine D2-like receptors in cocaine self-administration: studies with D2 receptor mutant mice and novel D2 receptor antagonists". Journal of Neuroscience. 22 (7): 2977–88. doi:10.1523/JNEUROSCI.22-07-02977.2002. PMC 6758322. PMID 11923462.
- ^ Gasior M, Paronis CA, Bergman J (January 2004). "Modification by dopaminergic drugs of choice behavior under concurrent schedules of intravenous saline and food delivery in monkeys". The Journal of Pharmacology and Experimental Therapeutics. 308 (1): 249–59. doi:10.1124/jpet.103.052795. PMID 14563783. S2CID 5879400.
- ^ Brooks JM, Sarter M, Bruno JP (September 2007). "D2-like receptors in nucleus accumbens negatively modulate acetylcholine release in prefrontal cortex". Neuropharmacology. 53 (3): 455–63. doi:10.1016/j.neuropharm.2007.06.006. PMC 2000917. PMID 17681559.